Position in PAHC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$336,576
-$271,668 QoQ
Shares Held
10,719
-2.5% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#112
of 206 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $48,172,745 across 31 Drug Manufacturers - Specialty & Generic names. PAHC ranks #22 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
419,136 | $6,655,879 | |
| 2 | ZTS |
Zoetis Inc.
|
81,282 | $5,840,924 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
8,944 | $4,846,127 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
26,150 | $4,407,321 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
120,099 | $4,163,832 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
122,056 | $3,003,798 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
85,581 | $2,899,484 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
152,601 | $2,446,194 |
All Filings in PAHC
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $336,576 | 10,719 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $608,244 | 10,997 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $399,901 | 10,704 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $457,400 | 11,305 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $480,918 | 18,830 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $246,708 | 11,550 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $203,910 | 9,710 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||